Navigation Links
Cephalon Launches Takeover Offer for Australian Biotechnology Company, Arana Therapeutics
Date:2/26/2009

ncial results could differ materially from those reflected in these forward-looking statements due to general financial, economic, regulatory and political conditions affecting the biotechnology and pharmaceutical industries as well as more specific risks and uncertainties facing Cephalon such as those set forth in its reports on Form 8-K, 10-Q and 10-K filed with the U.S. Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Therefore, you should not rely on any such factors or forward-looking statements. Furthermore, Cephalon does not intend to update publicly any forward-looking statement, except as required by law. The Private Securities Litigation Reform Act of 1995 permits this discussion.

HUMIRA(R) (adalimumab) is a registered trademark of Abbott Laboratories

REMICADE(R) (infliximab) is a registered trademark of Johnson & Johnson

Source: Cephalon, Inc.

Appendix A

Takeover Bid Conditions

Cephalon International Holdings, Inc.'s offer is proposed to be subject to the fulfillment of the following conditions. Capitalized terms have meanings set out in the glossary below.

(a) Minimum acceptance

Before and at the end of the Offer Period, Cephalon International has a relevant interest in at least 50.1% of Arana Shares.

(b) Adverse change conditions

(i) Material adverse change in respect of the Arana Group

During the Condition Period, no event, change or circumstance occurs, is announced or becomes known to Cephalon International (whether or not it becomes public) which has or could reasonably be expected to have a material adverse effect on the business, assets, liabilities, financial position, performance, profitability or prospects of the Arana Group taken as a whole.

(ii) I
'/>"/>

SOURCE Cephalon, Inc.
Copyright©2009 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3 4 5 6 7 8 9 10 11 12

Related medicine news :

1. Major Pharma Clinical Case Studies From Amgen, AstraZeneca, GSK, Intermune, Cephalon Inc, Sunesis Pharmaceuticals and Dartmouth Medical School During Fall Clinical Focused Programs
2. Cephalon Submits New Drug Application for TREANDA for the Treatment of Chronic Lymphocytic Leukemia
3. Cephalon Appoints Valli F. Baldassano as Executive Vice President and Chief Compliance Officer
4. Cephalon to Present at the 26th Annual JP Morgan Healthcare Conference
5. inVentiv Selling Solutions Selected to Provide Sales Team for Cephalon Inc.
6. Cephalon Appoints Gerald J. Pappert as General Counsel
7. Cephalon Reports Strong First Quarter Earnings
8. Cephalon Conference Call Invitation
9. Cephalon Announces FDA Advisory Committee Recommendation Against Approval of an Expanded Label for FENTORA
10. Biopharmaceutical Company, Cephalon, To Pay $425 Million & Enter Plea to Resolve Allegations of Off-Label Marketing
11. Ohio Sales Reps Information Launched Massive Government Investigation of Cephalon
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2013)... May 26, 2013 In the five years ... China has been growing at an average annualized rate ... due to rises in poultry prices as well as output ... people's diets as a healthier alternative to other meats. Additionally, ... China, much lower than the world average. And although pork ...
(Date:5/25/2013)... According to an article in the June 2013 issue ... million Americans tan indoors each year and an unknown number ... health risks. New research suggests that UV rays may ... brains of some tanners (Go to goo.gl/hdwnz). , “There ... say that I fully support this contention from a scientific ...
(Date:5/25/2013)... 2013 An experienced Chandler dentist has ... with JD Media Surge, LLC. , http://www.ChandlerDentalExcellence.com/Teeth-Whitening.php ... and, depending on the treatment, can be performed in ... the best method will be chosen for the individual ... visit. A special peroxide-based whitening gel is used along ...
(Date:5/25/2013)... (HealthDay News) -- Many viruses and parasites that affect ... -- a bacteria-borne illness than can result in liver ... parks, according to a veterinarian. These germs ... the air, said Dr. Susan Nelson, a clinical associate ... of these serious diseases can be fatal, even with ...
(Date:5/25/2013)... (PRWEB) May 25, 2013 Providing patients with ... Diet Doc team of weight management professionals. But, aside from ... and effectively, Diet Doc’s hCG diets also provide ... abuse during childhood like bullying, more control over their lives ... of dealing with the underlying factors of weight gain derived ...
Breaking Medicine News(10 mins):Health News:Poultry Farming Industry in China Industry Research Report – Now Available from IBISWorld 2Health News:Poultry Farming Industry in China Industry Research Report – Now Available from IBISWorld 3Health News:Sun Damage – Are UV Rays Addictive? 2Health News:Chandler Dentist Launches Teeth Whitening Service Page on Website in Partnership with JD Media Surge, LLC 2Health News:Hidden Dangers Dog Dog Parks 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 2Health News:hCGTreatments / Diet Doc hCG Diets & Weight Loss Plans Announces hCG Diet Plans for Those Suffering from Abuse-Related Weight Gain 3
... By Alan Mozes HealthDay Reporter , WEDNESDAY, ... suicide risk appears to be significantly higher among people ... The latest observation seems to confirm the findings of ... fully explained relationship between higher than average suicide rates ...
... hemorrhagic fever in humans, has no known cure or vaccine. ... scientists has uncovered a family of small molecules which appear ... inhibit its entry into human cells. The results are ... and are now online. Previous studies have shown ...
... Inserm research team in Toulouse, led by Dr Stein ... working with the "Modelling tissue and nociceptive stress" Host ... illusions described by many patients under regional anaesthetic. In ... Anesthesiology , the researchers demonstrated that anaesthetising an arm ...
... News) -- Many U.S. transplant surgeons unnecessarily shun organs ... safeguards that would protect and inform transplant recipients, a ... in the nation "overreacted" to a 2007 case in ... organs from a single donor unknowingly infected with HIV, ...
... January 20, 2011) Cancer scientists led by ... and collaborators at St Jude Children,s Research Hospital (Memphis) ... cells that carry them are organized in a more ... published today in Nature (DOI:10.1038/nature09733), challenge the ...
... By Charnicia Huggins HealthDay Reporter , ... tongue piercing as a form of self-expression, know that ... metal or plastic makes a difference when it comes ... collect more bacteria than plastic studs, potentially increasing the ...
Cached Medicine News:Health News:High Altitude Linked to Higher Suicide Risk -- Again 2Health News:High Altitude Linked to Higher Suicide Risk -- Again 3Health News:High Altitude Linked to Higher Suicide Risk -- Again 4Health News:Small molecules may prevent ebola infection 2Health News:How does anesthesia disturb self-perception? 2Health News:Cancer scientists discover genetic diversity in leukemic propagating cells 2Health News:Cancer scientists discover genetic diversity in leukemic propagating cells 3Health News:Metal Tongue Piercings Linked to Raised Infection Risks 2Health News:Metal Tongue Piercings Linked to Raised Infection Risks 3
(Date:5/23/2013)... May 23, 2013  A recently published clinical study ... Houston, Texas , demonstrates that 3D mammography (breast ... detection. The study, "Implementation of Breast ... was led by Stephen L. Rose ... the American Journal of Roentgenology (AJR). The ...
(Date:5/23/2013)... , May 23, 2013  The need to ... treatment continuum was highlighted prominently at the 108 ... Association (AUA), in San Diego.  According to SonaCare ... focused ultrasound (HIFU) technology, the need for image-guided ... for urologists to consider minimally invasive ablative treatments, ...
(Date:5/23/2013)... , May 23, 2013  Hologic, Inc. (Hologic ... a leading developer, manufacturer and supplier of premium ... an emphasis on serving the healthcare needs of ... study in a U.S. clinical practice comparing breast ... tomosynthesis) with conventional 2D mammography alone showed a ...
Breaking Medicine Technology:First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 2First Large-Scale U.S. Study Validates the Benefits of 3D Mammography (Breast Tomosynthesis) Exams 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 2Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 3Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 4Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 5Need for Image Guided Minimally Invasive Ablative Treatments Featured Prominently at American Urological Association (AUA) Annual Meeting 6First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 2First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 3First Large-Scale Population-Based Study in the U.S. Shows Hologic's 3D Mammography (Breast Tomosynthesis) Significantly Reduces Recall Rates While Simultaneously Improving Cancer Detection 4
...  UCB today announced new findings for Vimpat® (lacosamide) ... effects of the antiepileptic drug (AED) as an ...  The data demonstrate reduced seizure severity and improvements ...  These and other Vimpat® data were presented at ...
... 5, 2011 ForteBio®, Inc., a leading supplier of ... pharmaceutical products, today announced the launch of BLItz™, a ... the first time – to conduct label-free analyses of ... their lab bench. The new platform was unveiled today ...
Cached Medicine Technology:Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 2Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 3Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 4Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 5Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 6Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 7Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 8Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 9Long-term Use of Antiepileptic Drug Vimpat® (Lacosamide) C-V Reduced Seizure Frequency and Severity and Improved Health-related Quality of Life Measures 10ForteBio Introduces BLItz™, a Revolutionary, Micro-volume Label-free Analysis Platform for Personal Assays 2ForteBio Introduces BLItz™, a Revolutionary, Micro-volume Label-free Analysis Platform for Personal Assays 3
Anterior Interbody fusion with proven clinical performance. Large hole design. Request info fda status for sale....
... Jaguar Lumbar I/F Cage system is a ... separate the mechanical and biologic functions of ... Lumbar I/F Cage provides a device designed ... and uses autologous cancellous bone, the best ...
... images are transmitted through sorted ... picture and transmit it to ... flexoscopes are designed for rough, ... repaired at low cost if ...
... BAK/Proximity Interbody Fusion system ... and associated implantation instruments. ... a hollow, porous, square-threaded ... alloy (Ti-6Al-4V). Hollow, porous ...
Medicine Products: